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Epidermal keratinocytes undergo differentiation in
response to several stimuli to form the corni®ed
envelope, a structure that contributes to the barrier
function of skin. Although differentiation has been
extensively analyzed, the precise role of vitamin C
during this process is still not de®ned. Ascorbic
acid, besides acting as a radical scavenger, has been
shown to promote mesenchymal differentiation. In
this study, we found that keratinocytes grown in
ascorbate-supplemented medium developed a differ-
entiated phenotype, as demonstrated by enhanced
expression of marker genes and increase in corni®ed
envelope content. The pro-differentiating effects of
ascorbate were mediated by the protein-kinase-C-
dependent induction of activating protein 1 DNA
binding activity; indeed, down-modulation of
protein kinase C activity abolished differentiation
triggered by ascorbic acid. Although vitamin C
appeared to regulate the same signaling pathway
modulated by calcium, a classical in vitro inducer of
epidermal differentiation, nonetheless terminally dif-
ferentiated keratinocytes exhibited different ascor-
bate homeostasis and cellular antioxidant status.
Indeed, we found that, unlike calcium, differenti-
ation promoted by ascorbate was accompanied by (i)
an enhanced ascorbate transport, due to overexpres-
sion of speci®c transporters, (ii) a great ef®ciency of
dehydroascorbate uptake, and (iii) an increase in glu-
tathione content with respect to proliferating cells.
Ascorbic acid may be useful to promote epidermal
differentiation, avoiding depletion of hydrophilic
antioxidant stores. Key words: activating protein 1
(AP-1)/dehydroascorbate/glutathione/hSVCT1/hSVCT2. J
Invest Dermatol 118:372±379, 2002
S
everal studies have identi®ed a role for vitamin C in skin
repair, and this molecule is often used in vivo for its
healing, antiageing, and anticarcinogenic properties.
Studies performed with epidermis in toto demonstrated
that the wound healing process is accompanied by
oxidation of ascorbic acid (AA), and that other factors besides
collagen synthesis may enhance AA oxidation in the early stages of
tissue regeneration (Kim et al, 1994); in addition, AA has been
shown to be necessary for multistep production of bioengineered
skin substitutes (Auger et al, 2000).
Epidermal differentiation plays a central role during wound
repair. As keratinocytes migrate towards the upper layers of the
epidermis, the expression pattern of epidermal-speci®c genes
undergoes drastic changes (Reichert et al, 1993). In differentiating
keratinocytes, several genes, such as basal keratins K5 and K14, are
downregulated, whereas the expression of suprabasal markers, such
as K1 and K10, ®laggrin, involucrin, loricrin, and transglutaminases
(TGases) increases (Eckert et al, 1997). All of these proteins are
required for correct assembly of the corni®ed cell envelope (CE), a
specialized structure that represents the physical barrier between the
body and the environment and protects mammals from mechanical
and chemical insults (Hohl, 1990; Nemes and Steinert, 1999).
Among the transcription factors regulating tissue- and differenti-
ation-speci®c expression, the activating protein 1 (AP-1) plays a
major role (Welter and Eckert, 1995; Rossi et al, 1998). This
nuclear transcription factor consists of homodimers or heterodimers
between Fos (c-Fos, FosB, Fra-1, Fra-2), Jun (c-Jun, JunB, JunD),
and activating transcription factor (ATF2, ATF3, B-ATF) family
members (Karin et al, 1997), which modulate transcription by
binding to speci®c DNA regulatory elements in the promoter
region of targeted genes (the TRE and CRE sites) (Hai and
Curran, 1991). In the epidermis, the selectivity of genes regulated
by AP-1 is determined by distinct AP-1 complexes, which have a
differentiation-speci®c distribution, and by interactions with other
transcriptional regulators and/or distal regulatory elements. Thus,
the ®ne-tuned modulation of AP-1 DNA binding activity allows
the expression of various differentiation marker genes that have
AP-1 responsive elements in their regulatory regions (Lu et al,
1994; Yamada et al, 1994).
Vitamin C has been proved to regulate cell growth and
differentiation in culture models other than keratinocytes.
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Ascorbate is required for in vitro differentiation of several
mesenchyme-derived cell types (Farquharson et al, 1998; Otsuka
et al, 1999) and is needed for in vivo differentiation of connective
tissues, such as bone, muscle, and cartilage (Franceschi, 1992). In
particular, the commitment to an osteoblast phenotype requires the
formation of a collagen-containing matrix in response to AA, thus
providing a permissive environment for the expression of tissue-
speci®c genes, such as osteocalcin and alkaline phosphatase (Xiao et
al, 1997).
We have recently demonstrated that HaCaT keratinocytes possess
very ef®cient systems for maintaining high levels of intracellular AA,
which is accumulated in millimolar concentrations. Human
keratinocytes transport both reduced and oxidized forms of vitamin
C inside cells through two different mechanisms, an Na+-dependent
cotransporter for AA and a facilitative glucose transporter for
dehydroascorbic acid (DHA) (Savini et al, 2000). In addition,
HaCaT keratinocytes are able to enzymatically recycle vitamin C.
DHA is reduced to AA by cytosolic reductases (GSH-NADPH-
dependent, lipoic acid-NADH-dependent, and thioredoxin reduc-
tase), whereas ascorbyl free radical (AFR) is reduced to AA by plasma
membrane, mitochondrial, and microsomal AFR reductases (Savini
et al, 1999). Moreover, we have shown that accumulated vitamin C
protects HaCaT cells against UV-induced cell damage by acting as a
scavenger of reactive oxygen species and by interfering at multiple
levels with the AP-1 pathway. In normal human epidermal
keratinocytes and HaCaT cells, ascorbate increases fra-1 mRNA
levels and negatively modulates JNK activity, thus inhibiting
phosphorylation of endogenous c-Jun protein. These effects of AA
on the JNK/AP-1 pathway lead to a speci®c modi®cation of the
nature of AP-1 complexes (Catani et al, 2001).
On the basis of these ®ndings, we investigated the potential
regulatory role of ascorbate in epidermal differentiation. We found
that normal human epidermal keratinocytes and HaCaT cells
grown in ascorbate-supplemented medium showed a differentiated
phenotype, characterized by the expression of different marker
genes and CE formation. The pro-differentiating effects of AA
were mediated by induction of AP-1 activity, together with
induction of its upstream regulator, protein kinase C (PKC), a
kinase known to be essential for regulation of AP-1 (Rutberg et al,
1996). Moreover, we found that ascorbate-triggered differentiation
was accompanied by a more favorable antioxidant status with
respect to keratinocytes differentiated by calcium, the classical
inducer of epidermal differentiation. Indeed, AA-induced differ-
entiation increased glutathione levels and had speci®c effects on
vitamin C metabolism, including AA transport and recycling.
MATERIALS AND METHODS
Reagents Magnesium ascorbic acid-2 phosphate (AA-2P) was
obtained from Wako Pure Chemical Industries (Neuss, Germany).
[a-33P]-dCTP, [g-33P]-ATP, and [14C]-AA were purchased from
Amersham (Arlington Heights, IL). DHA was obtained from ICN
(Aurora, OH). Anti-K1 antibody was from Babco (Berkeley, CA).
Bisindolylmaleimide GF 109203X (PKC inhibitor) was from Calbiochem
(La Jolla, CA). All the other reagents, unless otherwise indicated, were
from Sigma Chemical (St. Louis, MO).
Cell cultures Cryopreserved normal human epidermal keratinocytes
(newborn foreskin) were obtained from Clonetics (San Diego, CA) and
grown in dishes coated with calf skin collagen type III (100 mg per ml
in 0.1 M acetic acid) in serum-free keratinocyte growth medium (Gibco,
Berlin, Germany) at 0.05 mM calcium, supplemented with 60 mg per ml
of bovine pituitary extract. Third passage normal human epidermal
keratinocytes were used for each experiment. HaCaT cells (Boukamp et
al, 1988) were kindly provided by Prof. N.E. Fusenig, German Cancer
Research Center, Heidelberg, Germany, and were grown in a 1:1
mixture of minimal essential medium and Ham's F-12 medium (Gibco)
supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum
(HyClone, Oud-Beijerland, Holland), 1.2 g per l Na bicarbonate, 1%
(vol/vol) nonessential amino acids, and 15 mM HEPES, at 37°C with
5% CO2 in a humidi®ed atmosphere. No antibiotics were used. Cells
were split 1:6 twice weekly and fed 24 h before each experiment.
Determination of CEs CEs were extracted from proliferating or
differentiating cells by exhaustive boiling and sonication in 2% sodium
dodecyl sulfate (SDS), 20 mM dithiothreitol (DTT), 0.1 M Tris±HCl
pH 8.0, and 0.5 mM ethylenediamine tetraacetic acid (EDTA), as
described previously (Steven and Steinert, 1994). CEs were quanti®ed by
spectrophotometry at 600 nm.
Reverse transcription polymerase chain reaction (RT-
PCR) Two to ®ve million normal human epidermal keratinocytes
and HaCaT cells were used to isolate total RNA by Trizol (Gibco).
Ampli®cation of TGase 1, loricrin, and 18S rRNA was performed as
described previously (Rossi et al, 2000).
For ampli®cation of sodium-dependent ascorbate transporters
(hSVCT1 and hSVCT2), 1 mg of total RNA was reverse transcribed
using the Superscript Preampli®cation System and oligo-dT primer
(Gibco), following the manufacturer's instructions; 10% of the ®rst strand
reaction was then PCR ampli®ed. Control reactions were performed in
order to ensure complete removal of DNA. PCR ampli®cation condi-
tions were carefully examined to stop the reaction during the exponential
phase of ampli®cation. The PCR was carried out in the presence of 3
mCi of [a-33P]-dCTP. The ampli®cation parameters were as follows:
94°C, 30 s; 60°C, 30 s; 68°C, 2 min. Linear ampli®cation was observed
after 20 cycles. Twenty microliters of the reaction were electrophoresed
on a 6% (wt/vol) polyacrylamide gel, which was then dried and
autoradiographed. The primers were as follows: hSVCT1 (+) 5¢-473
ATTTGGCACCCACGGATACG 492-3¢; (±) 5¢-851 TCAAGG-
TCAGGACATAGCAGAGC 829-3¢ (Genbank accession number
AF170911); hSVCT2 (+) 5¢-57 AGAAGGCAAATACGAAGACGAGG
79-3¢; (±) 5¢-601 GCTCTGCTGTTCCATTGGCAAC 580-3¢
(Genbank accession number AJ269478).
Products were validated by size determination and sequencing.
Western blot After each treatment, cells were resuspended in lysis
buffer (25 mM Tris±HCl pH 8.0, 1 mM EDTA, 0.5% SDS) and
sonicated. 10±20 mg of total proteins were subjected to SDS
polyacrylamide gel electrophoresis on a 10% polyacrylamide gel and then
electroblotted onto a PVDF membrane. Blots were blocked with 5%
nonfat dry milk (Biorad, Hercules, CA) and then incubated with anti-K1
primary antibody (Babco). After washings and incubation with the
horseradish-peroxidase-conjugated secondary antibody, detection was
carried out with enhanced chemiluminescence (Amersham).
Electrophoretic mobility shift assay (EMSA) Nuclear extracts were
prepared as previously described (Schreiber et al, 1989; Lee et al, 1996).
The oligonucleotides were AP-1 consensus CGCTTGATGAGTC-
AGCCGGAA and AP-1 mutant CGCTTGATTAGTTAGCCGGAA.
The oligonucleotides were end-labeled with [g-33P]-ATP and mobility
shift experiments were performed as described previously (Lee et al,
1996). The complexes were resolved on nondenaturing 6% (wt/vol)
polyacrylamide gels in 0.5 3 TBE buffer for 1 h at 14 V per cm and
autoradiographed overnight.
Transient transfections of keratinocytes Transient transfections
were performed in triplicate using lipofectin (Gibco) following the
manufacturer's instructions. Cells were transfected as described previously
(Rossi et al, 1998) with both wild-type and AP-1 mutated minimal
loricrin promoters placed upstream of the chloramphenicol
acetyltransferase (CAT) reporter gene (Rossi et al, 1998); the transfection
ef®ciency was monitored by using a thymidine kinase b-galactosidase (b-
gal) construct (Clontech, Palo Alto, CA). After transfection, cells were
treated with 1 mM AA-2P for 5 h before harvesting. CAT activity was
assayed using the CAT Enzyme Assay System (Promega, Madison, WI),
according to the manufacturer's protocol. b-gal activity was performed
using the b-galactosidase Enzyme System (Promega), again according to
the manufacturer's protocol. CAT activities were normalized by protein
content and b-gal activity. The relative CAT values are the average of
three independent experiments, each performed in triplicate.
PKC activity After each treatment, cells were washed twice with ice-
cold PBS, resupended in homogenization buffer A [20 mM Tris±HCl
pH 8.0, 10 mM ethyleneglycol-bis(b-aminoethyl ether)-N,N,N¢,N¢-
tetraacetic acid, 2 mM EDTA, 2 mM DTT, 1 mM phenylmethylsulfonyl
¯uoride, 25 mg per ml aprotinin, 10 mg per ml leupeptin], and sonicated.
After centrifugation at 100,000 3 g for 1 h at 4°C, the supernatant was
collected as the cytosol fraction and the pellet, resuspended in
homogenization buffer B (1% Triton X-100 in buffer A), was sonicated
for 10 s. The suspension was then centrifuged at 15,000 3 g for 15 min
at 4°C and the supernatant was collected as the membrane fraction. Two
micrograms of proteins from membrane and cytosol fractions were
assayed for PKC activity in reaction buffer [20 mM Tris±HCl, pH 7.5,
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5 mM Mg acetate, 10 mg per ml phosphatidylserine, with or without
1 mg per ml dioctanoyl-glycerol vesicles, 0.1 mM CaCl2, 25 mM acylated
myelin basic protein substrate (fragment 4±14), 0.01 mM ATP]
containing 5 mCi [g-33P]-ATP. Reactions were incubated for 10 min at
30°C, spotted on P81 paper (Whatmann), and washed four times in
75 mM H3PO4. The bound radioactivity was determined with an LKB
1217 RACKBETA liquid scintillation spectrometer. To calculate the
amount of radioactivity speci®cally incorporated into the peptide
substrate, the nonspeci®c binding to P81 paper was determined
performing the reaction in the absence of peptide. Experiments were also
carried out with the same mixture as above plus 50 mM PKC
pseudosubstrate (RFARKGALRQKNVHEVKN) (House and Kemp,
1987) to ensure the speci®city of reaction.
AA and DHA uptake Uptake assays were carried out by using both
high performance liquid chromatography (HPLC) with ultraviolet
detection and scintillation spectrometry. HPLC analysis was performed as
described previously (Savini et al, 2000). Brie¯y, 2.5 3 106 cells were
incubated in transport medium (5 mM KCl, 1.9 mM KH2PO4, 5.5 mM
glucose, 0.3 mM MgSO4, 1 mM MgCl2, 0.3 mM CaCl2, 10 mM
HEPES, 147 mM NaCl, 1.1 mM Na2HPO4 pH 7.4) containing AA
(with 1 mM DTT to prevent AA oxidation) or DHA. After incubation
at 37°C, AA was directly extracted with ice-cold 70% methanol
containing 1 mM EDTA and the remaining cell monolayer was analyzed
for protein content by the method of Bradford (1976). As DHA does
not adsorb at 265 nm (absorbance peak of AA), it was quanti®ed by
treating the samples with 10 mM DTT for 10 min.
For scintillation spectrometry measurements, 8 3 105 cells in a 9 cm2
dish were incubated in 300 ml of transport medium containing [14C]-AA
(speci®c activity 7 mCi per mmol) or [14C]-DHA. The latter compound
was prepared by incubating [14C]-AA with 2 U of ascorbate oxidase
(Boehringer Mannheim, Mannheim, Germany) immediately before it
was added to the incubation medium; complete oxidation was veri®ed
by HPLC. In time-dependent experiments, 0.2 mCi of the labeled
compound was used. For deoxyglucose (DOG) uptake, the incubation
medium contained 0.2 mCi of [1,2-3H]-2-DOG (50 Ci per mmol) and
0.3 mM of 2-DOG. At ®xed intervals, cells were harvested, lyzed, and
assayed by liquid scintillation spectrometry as described previously (Savini
et al, 2000). For accumulation studies, cells were incubated with 0.1±0.4
mCi [14C]-AA or [14C]-DHA or [1,2-3H]-2-DOG and adequate concen-
trations (0±10 mM of AA, 0±15 mM of DHA, and 0±3 mM of DOG,
respectively) of the respective unlabeled compounds.
Glutathione content Intracellular reduced and oxidized glutathione
content was quanti®ed by a DTNB-glutathione reductase recycling assay,
according to the method of Anderson (1985).
Enzymatic activities DHA reductase activity was measured as
previously described (Savini et al, 2000). Samples (containing 0.2±0.3 mg
of protein) were incubated at 37°C for 20 min in 50 mM Tris±HCl
pH 7.5 containing 1 mM EDTA and 1 mM DHA. After incubation and
precipitation of proteins by methanol, ascorbate content was evaluated by
HPLC. To test NADPH/GSH- and NADH/lipoic-acid-dependent
DHA reductase activities, single cofactors were added to the reaction
mixture. Corrections have been made for nonenzymatic reduction of
DHA by endogenous reduced glutathione (GSH).
AFR-reductase activity was measured spectrophotometrically, through
the rate of ascorbate-free-radical-dependent oxidation of NADH, by
monitoring the decrease in 340 nm absorbance (E = 6.2 per mM per
cm) at 25°C (Savini et al, 1999). Corrections have been made for direct
oxidation of NADH by homogenates. The assay mixture contained
0.05 mM Tris±HCl buffer pH 7.8, 1 mM EDTA, 0.1 mM NADH,
1 mM ascorbate, and aliquots of each sample. The reaction was started
by adding 0.28 U of ascorbate oxidase to generate ascorbate free radical.
Transmembrane AFR-reductase activity was measured as previously
described, by monitoring at 265 nm the prevention of ascorbate
autoxidation in the presence or in the absence of cells (Savini et al,
1998).
Thioredoxin reductase activity was assessed by an insulin-reducing
assay (Holmgren and Bjornstedt, 1995).
Statistics and kinetic calculations Statistical analysis of means 6 SD
was conducted with the program Stat View 4.02 for Macintosh (Abacus
Concept, Berkeley, CA).
Kinetics for all substrates were determined when transport was linear.
The apparent Km values were obtained by ®tting the initial uptake
velocity versus substrate concentration data directly to the Michaelis±
Menten equation. The apparent Km values were obtained using a Sigma
Plot vs 101 program (Jandel Corporation).
RESULTS
Ascorbate promotes CE formation in vitro To investigate
the possibility that human epidermal keratinocytes undergo
differentiation after loading with ascorbate, we studied whether
vitamin C could affect the process of CE formation. We employed
AA-2P, as it is a stable vitamin C derivative that does not generate
oxidation and degradation products in the culture medium and is
taken up as ascorbate after cleavage by plasma membrane
phosphatases. Ascorbate is then accumulated against a
concentration gradient with a speci®c transport system saturable
at about 1 mM extracellular concentration (Savini et al, 1999).
Proliferating keratinocytes can be induced to differentiate in vitro
by changing Ca2+ concentrations in the culture medium; indeed,
epidermal keratinocytes, grown in high calcium medium, express
differentiation-speci®c genes and form insoluble CEs (Hennings et
al, 1980). Therefore, we extracted and quanti®ed CEs obtained
from proliferating or differentiating normal human epidermal
keratinocytes and compared them with CEs from ascorbate-
supplemented cells. To this end, normal human epidermal
keratinocytes grown in low calcium medium (0.05 mM CaCl2)
were shifted to 1.2 mM CaCl2 (high calcium), or treated with
1 mM AA-2P, and cultured for an additional 1 and 3 d before
harvesting; the formation of CEs was then monitored by spectro-
photometric analysis as a marker of terminal differentiation.
As shown in Fig 1, human keratinocytes signi®cantly increased
their CE content just 24 h after raising calcium concentrations
(white bars); the percentage of CEs further increased (about 2.5-fold
over control cells) after 72 h (gray bars). We found that AA-2P-
treated human keratinocytes showed the same CE content as cells
cultured in 1.2 mM CaCl2, thus suggesting a differentiating role for
vitamin C in epidermis.
Similar results were obtained with the spontaneously immorta-
lized HaCaT cells induced to differentiate by growing them over
con¯uence in the presence of 1.5 mM CaCl2 or in AA-2P-
supplemented medium, although these cells were less ef®cient in
forming CEs (data not shown).
Ascorbate-mediated keratinocyte differentiation is linked to
induction of PKC activity Calcium-dependent differentiation
requires activation of the PKC signaling cascade, which is essential
for the upregulation of AP-1-dependent gene expression. In order
to gain further insight into the possible mechanism accounting for
the differentiating properties of ascorbate, we assayed PKC activity
in primary normal human epidermal keratinocytes grown either in
high calcium conditions or in ascorbate-supplemented medium.
As shown in Fig 2, the total level of PKC activity was increased
in both Ca2+-treated (white bars) and AA-2P-treated (gray bars)
Figure 1. CE formation is induced by ascorbate. Normal human
keratinocytes were grown for 1 d (white bars) or 3 d (gray bars) either in
0.05 or 1.2 mM CaCl2 or in 1 mM AA-2P. CEs were extracted by
exhaustive boiling and sonication and then quanti®ed by
spectrophotometry at 600 nm. Results are shown as OD600 per mg of
protein. Data are the means 6 SD of three independent experiments.
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normal human epidermal keratinocytes. Moreover, subcellular
fractionation revealed that, in untreated cells (black bars), more than
70% of total PKC activity was recovered in the soluble, cytosolic
fraction, thus suggesting that the enzyme was in an inactive state; in
contrast, in keratinocytes incubated with high Ca2+ or with AA-
2P, PKC underwent a redistribution to the particulate fraction,
suggesting that the enzyme was activated through membrane
association. Induction of kinase activity was speci®c for PKC, as
revealed by using a pseudosubstrate that maintains PKC in an
inactive form by occupying the active site of the enzyme (House
and Kemp, 1987): indeed, incubation with the peptide inhibited
both the basal and induced kinase activity (Fig 2). Similar results
were obtained with the transformed HaCaT cell line (data not
shown). These ®ndings suggest that endogenous activation of PKC
is associated with triggering the ascorbate-induced terminal differ-
entiation program.
Ascorbate-mediated activation of PKC induces the
expression of differentiation-speci®c genes through an AP-
1-dependent pathway As almost all of the biologic markers
identi®ed in differentiating keratinocytes appear to be under the
control of the AP-1 transcription factor (Welter and Eckert, 1995;
Rossi et al, 1998), which in turn is activated by PKC, we
investigated the effects of vitamin C on this transcriptional
regulation. To this end, we performed EMSA on nuclear extracts
derived from normal human epidermal keratinocytes grown in the
presence of AA-2P or high CaCl2 concentrations.
Like calcium (Fig 3a, lane 2), ascorbate was able to enhance the
ability of nuclear extracts to bind a speci®c oligonucleotide
containing an AP-1 responsive site, both in normal human
keratinocytes (Fig 3a, lane 3) and in HaCaT cells (data not
shown). This ascorbate-mediated DNA binding induction led to
gene transactivation, as assessed by transient transfection studies
performed with a vector containing the CAT gene under the
control of the loricrin promoter, which contains AP-1 responsive
sites (Welter and Eckert, 1995). Agreeing with the ability of
ascorbate to induce DNA binding activity, we found that
incubation with AA-2P induced a 3-fold increase of CAT activity
over untreated cells, both in normal human keratinocytes and in
HaCaT cells (Fig 3b, white bars, and data not shown). The
ascorbate-induced increase of CAT activity of the wild-type
loricrin promoter was completely abolished by its counterpart
containing an AP-1 mutated site (Fig 3b, gray bars), thus suggesting
that ascorbate-mediated activation of the loricrin promoter requires
an intact AP-1 element.
Consistent with these results, we found that the expression of
differentiation-speci®c genes was upregulated both in AA-2P- and
Ca2+-treated cells. In differentiating normal human keratinocytes
(Fig 3c, lane 4), the levels of TGase1 and loricrin transcripts were
much higher than those found in control cells (compare lanes 1 and
4); TGase1 and loricrin expression was upregulated in a similar way
in AA-2P-treated cells (Fig 3c, lane 2). As revealed by immuno-
blotting analysis, the expression of the suprabasal 68 kDa K1 was
also induced as keratinocytes proceeded towards terminal differen-
tiation; thus, CaCl2 treatment (1.2 mM for 5 d) increased K1
protein levels (Fig 3d, lane 4) and vitamin C exerted a similar effect
(Fig 3d, lane 2). Although less evident, some increase in TGase3
expression was also observed (data not shown).
In accordance with our hypothesis, we found that pharmacologic
down-modulation of PKC activity with GF 109203X (Toullec et
al, 1991) partially abolished the calcium-induced, as well as the
ascorbate-induced, keratinocyte differentiation through a decrease
in the AP-1 DNA binding activity (Fig 3a, lanes 4, 5). As a
consequence of inhibition of AP-1 DNA binding activity, the PKC
inhibitor blocked the expression of differentiation-speci®c genes.
Indeed, GF 109203X inhibited calcium-dependent increases in
TGase1 and loricrin mRNA (Fig 3c, lane 5) as well as the calcium-
dependent increase in K1 protein levels (Fig 3d, lane 5). A similar
effect on the expression of differentiation markers was also seen in
ascorbate-loaded keratinocytes (Fig 3c, lane 3, and Fig 3d, lane 3).
The involvement of PKC in ascorbate-induced differentiation
was further supported by the ®nding that the competitive inhibitor
GF 109203X was also able to suppress the increase in CE content
observed in normal human keratinocytes induced to differentiate
either with 1.2 mM CaCl2 or with 1 mM AA-2P (Fig 3e).
Comparable results were obtained with HaCaT cells grown over
con¯uence in the presence of 1.5 mM calcium or in ascorbate-
supplemented medium (data not shown).
Together, these data indicate that vitamin C can activate the
epidermal differentiation program through a PKC/AP-1-depend-
ent pathway.
Ascorbate-mediated differentiation increases vitamin C
transport As the differentiation program per se is often
accompanied by changes in capacity for antioxidant defence
(Berghard et al, 1990; Harris, 1992), we investigated whether
vitamin C transport and recycling could be modulated in
keratinocytes induced to differentiate with either AA-2P or
calcium.
The recent cloning of two sodium-dependent L-AA transport-
ers, hSVCT1 and hSVCT2 (Rajan et al, 1999; Tsukaguchi et al,
1999; Wang et al, 1999), led us to investigate the expression of these
transporters and their possible modulation during differentiation.
RT-PCR analysis performed with primers speci®c for either
hSVCT1 or hSVCT2 (Fig 4) indicated that both transcripts were
present in HaCaT cells (Fig 4, lane 1) as well as in normal human
keratinocytes (Fig 4, lane 4), although with different abundances.
Increase in extracellular calcium (Fig 4, lanes 3, 6) did not affect the
expression of AA transporters; in contrast, cells grown in AA-2P-
supplemented medium showed a signi®cant increase in both
transcripts, the hSVCT2 mRNA being the most affected (Fig 4,
lanes 2, 5).
Increased expression of hSVCT1 or hSVCT2 was accompanied
by an increased AA transport. As biochemical analyses required
large amounts of biologic material, and as HaCaT cells behaved like
normal human keratinocytes in terms of differentiation, under our
experimental conditions, all studies on vitamin C metabolism were
carried out with this cell line.
As shown in Fig 5, both time course (panel a) and dose±response
(panel b) experiments showed that AA-2P-differentiated HaCaT
cells had an increased ability to take up AA. In fact, although these
cells contained a high amount of AA (about 25 mM), an increased
Figure 2. Ascorbate-mediated differentiation involves PKC
activation. PKC activity of normal human keratinocyte cells.
Keratinocytes were grown either in high calcium conditions (white bars)
or in AA-2P-supplemented medium (gray bars); after incubation, proteins
from membrane and cytosol fractions were assayed for PKC activity as
described in Materials and Methods. Total PKC activity was also measured
and compared to proliferating cells grown in low calcium medium (black
bars). Experiments were also carried out with 50 mM PKC
pseudosubstrate (RFARKGALRQKNVHEVKN) to ensure speci®city of
the reaction (hatched bars). Data are the means 6 SD of triplicate
determinations carried out in three different experiments.
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AA transport was measured (Vmax of 195 pmol per min per 10
6
cells) with respect to AA-untreated, proliferating cells (Vmax of
120 pmol per min per 106 cells). In contrast, Ca2+-differentiated
cells showed the same ability as control cells to import AA (Vmax of
116 pmol per min per 106 cells). The same af®nity was observed in
treated and untreated cells (apparent Km values: 213 mM for control
cells versus 207 mM and 209 mM for AA-2P- and Ca2+-differen-
tiated cells, respectively). AA ef¯ux was also checked, but no AA
leakage was detected in our experiments. Data from kinetic analysis
were consistent with the observed increase of hSVCT1 and
hSVCT2 messengers only in AA-2P-differentiated cells.
We previously demonstrated that, in HaCaT cells, the oxidized
form of vitamin C was also ef®ciently transported by facilitative
glucose transporters (Savini et al, 2000), possibly by GLUT 1,
whose expression in keratinocytes has been well documented
(Gherzi et al, 1992). Thus, we investigated DHA uptake after
differentiation induced by AA-2P or Ca2+. DHA uptake re¯ects
both its transport and reduction to AA inside the cell (Vera et al,
1995; Savini et al, 2000); we therefore carried out rapid uptake
assays (5 min). This time span was chosen as the reduction process
was not a rate-limiting step. As shown in time course and dose±
response experiments (Fig 5c,d), AA-2P-differentiated cells dis-
played almost the same kinetics of transport in comparison to
control cells (apparent Km 1.24 vs 1.22 mM; Vmax 4.23 vs
4.39 nmol per min per 106 cells), whereas Ca2+-induced differen-
tiation led to a decreased transport of the oxidized form of vitamin
C (apparent Km 1.20 mM; Vmax 1.10 nmol per min per 10
6 cells).
Figure 4. Ascorbate modulates the expression of sodium-
dependent vitamin C transporters hSVCT1 and hSVCT2. RT-
PCR analysis of total RNA isolated from normal human keratinocyte
and HaCaT cells. Cells were grown for 5 d in low (lanes 1, 4) or high
(lanes 3, 6) calcium conditions, or in culture medium supplemented with
1 mM AA-2P (lanes 2, 5). Total RNA was reverse transcribed and
ampli®ed either with hSVCT1 (upper panel) or hSVCT2 (middle panel)
speci®c primers; ampli®cation of the 18S rRNA (lower panel) is shown as
loading control. Scanning densitometry is also indicated: values are
reported as fold over control, arbitrarily set to 100, after normalization
with 18S rRNA. Blots are representative of four different experiments.
Figure 3. Ascorbate induces differentiation by regulating PKC-dependent AP-1 activity. (a) EMSA of nuclear extracts puri®ed from normal
human keratinocytes. Keratinocytes were grown in low calcium medium (lane 1), in the presence of 1.2 mM CaCl2 (lane 2), or 1 mM AA-2P (lane 3)
for 5 d. Samples coincubated with 0.5 mM GF 109203X are also shown (lanes 4, 5). Speci®city controls consist of binding competition experiments of
the sample shown in lane 3 treated with a 50-fold molar excess of mutant AP-1 oligonucleotide (lane 6) and unlabeled consensus AP-1 oligonucleotide
(lane 7). The radiograph is representative of three independent experiments. (b) CAT activity of keratinocytes transfected with an AP-1-containing
promoter. Normal human keratinocyte cells were transiently transfected with the wild-type (white bars) and AP-1 mutated (gray bars) loricrin promoter
CAT reporter vectors and left untreated or treated with AA-2P. Data are expressed as percentage of CAT activity over untreated cells, arbitrarily set to
100%. CAT activities were normalized by protein content and transfection ef®ciency (see Materials and Methods). Results are means 6 SD of triplicate
determinations carried out in three different experiments. (c) Analysis by RT-PCR of differentiation-speci®c markers in the presence of PKC inhibitor.
Normal human keratinocytes were grown for 5 d in 0.05 mM Ca2+ (lane 1), 1 mM AA-2P (lane 2), 1 mM AA-2P plus 0.5 mM GF 109203X (lane 3),
1.2 mM Ca2+ (lane 4), or 1.2 mM Ca2+ plus 0.5 mM GF 109203X (lane 5). Total RNA was reverse transcribed and ampli®ed either with TGase1
(upper panel) or loricrin (middle panel) speci®c primers as well as primers speci®c for the 18S rRNA (lower panel) as a loading control. Blots are
representative of three independent experiments. (d) Western blot analysis of proteins isolated from normal human keratinocytes. Cells were grown as
above and cellular extracts were puri®ed and immunoblotted with anti-K1 antibody. The blot is representative of three similar experiments. (e) CE
formation in the presence of PKC inhibitor. Normal human keratinocytes were grown as indicated above and CE content was assayed by
spectrophotometry. Results are shown as OD600 per mg of protein. Data are the means 6 SD of three independent experiments.
376 SAVINI ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
The activity of transporters was checked by measuring the transport
of deoxyglucose (which is accumulated as deoxyglucose-6-phos-
phate). As shown in Fig 5 (panels e, f), the decrease in deoxyglucose
transport paralleled that observed for DHA: this observation was
consistent with the reported down-modulation of GLUT1 expres-
sion by calcium in keratinocytes (Gherzi et al, 1992).
Preliminary results obtained with normal human keratinocytes
suggest that these data could also be extrapolated to primary
cultures (data not shown).
Altogether, these results indicate that AA-induced differentiation
was characterized by an improved ability to import vitamin C, both
by increasing AA transport and by maintaining basal DHA
transport, which was otherwise inhibited by calcium-triggered
differentiation.
Ascorbate-mediated differentiation modulates vitamin C
recycling Once inside the cell, vitamin C is maintained in the
reduced form by different enzymatic systems; therefore, we
addressed whether differentiation induced changes in the
enzymatic activities involved in vitamin C recycling.
AA-2P-induced differentiation led to a decreased intracellular
AFR-reductase activity in HaCaT cells (53% 6 3%), whereas
transmembrane AFR-reductase and DHA-reductase activities were
not affected (Table I). On the other hand, calcium-mediated
differentiation was accompanied by increased intracellular (180% 6
10%) and transmembrane AFR-reductase (138% 6 5%) activities
with respect to untreated cells (Table I). At the same time,
enzymatic DHA reduction was decreased with respect to prolif-
erating cells (76% 6 4%), with the NADPH/GSH-dependent
activity being the most affected (46% 6 2%) and the thioredoxin
and NADH-lipoic-acid-dependent reductases slightly affected.
Moreover, we found that total glutathione content of calcium-
treated cells was drastically decreased (37% 6 2%) in comparison
with untreated cells; in contrast, AA-2P-differentiated cells showed
increased intracellular GSH levels (150% 6 8%) with respect to
control cells.
DISCUSSION
AA plays an important role in epithelial cells as a protective agent
against oxidative stress and promoter of the wound healing process.
In this study, we have demonstrated that vitamin C is a direct
modulator of keratinocyte differentiation, and that ascorbate-
triggered differentiation proceeds through a PKC-dependent
activation of the AP-1 transcription factor.
Cultured keratinocytes are induced to differentiate in response to
several extracellular stimuli, among which calcium plays a key role
(Hennings et al, 1980). Ca2+-mediated events leading to keratino-
cyte maturation are regulated by distinct AP-1 binding complexes
(Rutberg et al, 1996; Rossi et al, 1998). Antibody staining studies
Figure 5. Ascorbate and calcium exert
different effects on vitamin C uptake. (a)
Time-dependent uptake of AA by HaCaT cells.
Control cells (d) and keratinocytes differentiated
either with CaCl2 (j) or AA-2P (m) were
incubated with 0.2 mCi [14C]-AA for the
indicated times; then, AA uptake was determined
by scintillation spectrometry. Values are the means
of three independent experiments (SD < 7%). (b)
Concentration dependence of AA uptake by
HaCaT cells. Cells, treated as above, were
incubated with [14C]-AA together with the
respective unlabeled compound for 2 h; then, AA
uptake was determined by scintillation
spectrometry. Values are the means of three
independent experiments (SD < 5%). (c)Time-
dependent uptake of DHA by HaCaT cells.
Control cells (d) and keratinocytes differentiated
either with CaCl2 (j) or AA-2P (m) were
incubated with 0.2 mCi [14C]-DHA for the
indicated times; then, DHA uptake was
determined by scintillation spectrometry. Values
are the means of three independent experiments
(SD < 4%). (d) Concentration dependence of
DHA uptake by HaCaT cells. Cells, treated as
above, were incubated with [14C]-DHA together
with the respective unlabeled compound for 5¢;
then, DHA uptake was determined by scintillation
spectrometry. Values are the means of three
independent experiments (SD < 7%). (e) Time-
dependent uptake of DOG by HaCaT cells.
Control cells (s) and keratinocytes differentiated
either with CaCl2 (h) or AA-2P (n) were
incubated with 0.2 mCi [1,2-3H]-2-DOG for the
indicated times; then, DOG uptake was
determined by scintillation spectrometry. Values
are the means of three independent experiments
(SD < 6%). ( f ) Concentration dependence of
DOG uptake by HaCaT cells. Cells were
incubated with [1,2-3H]-DOG together with the
respective unlabeled compound for 5¢; then,
DOG uptake was determined by scintillation
spectrometry. Values are the means of three
independent experiments (SD < 6%).
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have demonstrated that, in the spinous layer of the epidermis, AP-1
heterodimers consist mainly of Fra-1 and JunD, whereas Fra-2 and
JunB complexes predominate in the granular layer (Welter and
Eckert, 1995). In differentiating cells, calcium increases AP-1 DNA
binding activity and affects the composition of AP-1 complexes via
obligatory activation of PKC (Rutberg et al, 1996). We found that,
like calcium, AA stimulated the expression of genes associated with
a differentiated phenotype, such as suprabasal keratins (K1), TGases
(TGase1 and TGase3), and loricrin, both in primary and trans-
formed keratinocytes. Vitamin C is also necessary for the
improvement of the lipid pro®le, and thus the barrier formation
of the stratum corneum, in reconstructed human epidermis (Ponec
et al, 1997). These ®ndings reveal a new role for vitamin C in skin
biology as an inducer of differentiation.
The conversion of basal keratinocytes to a more differentiated
phenotype, characterized by the formation of CE, was mediated
through the ascorbate-induced activation of AP-1. Indeed, we have
previously shown that vitamin C regulated AP-1 activity by
modulating fra-1 expression and by inhibiting the JNK-mediated
phosphorylation of c-Jun (Catani et al, 2001); thus, the altered
composition of AP-1 dimers may specify the differentiation-
dependent pattern of gene expression. AP-1 is a crucial target for
redox modulators both in keratinocytes (Rossi et al, 2000) and in
other models (Melino et al, 1997, 2000). Furthermore, we
demonstrated that AA activated PKC by translocating it from the
cytosol to the membrane and that pharmacologic down-modula-
tion of PKC in differentiating keratinocytes partially abolished the
ascorbate-induced AP-1 DNA binding activity and the expression
of AP-1-targeted genes. The induction of PKC is of particular
relevance, considering that this enzyme contains redox-sensitive
cysteine residues both in regulatory and catalytic domains
(Gopalakrishna and Jaken, 2000). The availability of large amounts
of AA may activate PKC either by relieving its autoinhibition via
the regulatory domain or by preserving the free sulfydryls needed
for catalytic activity.
Although both AA and Ca2+ act as differentiating agents in a
similar way, nonetheless we report here that, at the end of
differentiation, keratinocytes were characterized by different vita-
min C homeostasis and glutathione levels. Exposure to high levels
of exogenous AA increased cellular ef®ciency of transport systems
rather than recycling ability. Our results demonstrated that AA
transport was achieved through an enhanced expression of the
transporters hSVCT1 and hSVCT2. It is noteworthy that
keratinocytes expressed both systems, whereas a speci®c distribu-
tion of the two transporters has been reported in mammalian
tissues, with hSVCT1 being expressed in intestine, kidney, and
liver, and hSVCT2 transcripts being ubiquitous (Tsukaguchi et al,
1999). In our model, both transporters appear to contribute to AA
accumulation inside the cell: nonetheless, further studies are
necessary to clearly delineate the physiologic relevance of these
two transporters in skin and to establish which transporter activity
predominates in vivo.
Furthermore, AA-mediated differentiation increased intracellular
glutathione levels, helping cells to maintain a well-balanced
antioxidant status, whereas Ca2+-induced differentiation induced
glutathione de®ciency. Thus, we suggest that Ca2+-differentiated
keratinocytes must increase ascorbate utilization in order to
compensate for intracellular glutathione depletion and maintain
the redox balance; consequently, although they were less ef®cient
in DHA transport and reduction, they were better able to recycle
both intracellular and extracellular AFR than proliferating cells.
Transmembrane AFR-reductase activity has been shown to be
modulated also in TPA-induced differentiation of HL-60 cells
(Buron et al, 1993); moreover, it has been described previously that
other antioxidant enzymes showed enhanced expression in
glutathione-depleted cells (Salvemini et al, 1999). In contrast,
ascorbate-mediated differentiation led to a reduced AFR-reductase
activity showing that this enzymatic activity was regulated by redox
conditions.
In conclusion, we have shown that vitamin C has a novel
signaling function, being able to trigger skin differentiation and to
overcome the differentiation-dependent oxidative stress. Thus,
vitamin C might be employed as a drug permitting faster recovery
of skin integrity and strength during wound healing, as it (i)
regulates epidermal differentiation via activation of PKC, which is
itself a modulator of wound healing (Chandrasekher et al, 1998),
and (ii) protects keratinocytes against oxidative stress, particularly
during the in¯ammatory phase of wound repair, via improvement
of the hydrophilic antioxidant status inside cells.
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